A bipartisan group of U.S. senators has attempted to prevent a sweeping federal prohibition on intoxicating hemp-derived products from taking effect, introducing legislation that would establish federal oversight and consumer protections in place of the restrictions scheduled to begin Dec. 11.
Sens. Amy Klobuchar (D-Minn.) and Tim Sheehy (R-Mont.) introduced the Hemp Guardrails Act on Nov. 17. The proposal would establish a federal regulatory framework for hemp-derived cannabinoid products, addressing concerns about youth access, product safety and inconsistent oversight while allowing certain products to remain on the market.
The legislation represents the latest effort by lawmakers to intervene in a federal crackdown on intoxicating hemp products. Congress approved restrictions in November 2025 as part of a government funding package, effectively closing a loophole created by the 2018 Farm Bill. That legislation legalized hemp containing no more than 0.3% delta-9 THC on a dry-weight basis, but its definition allowed manufacturers to extract and concentrate cannabinoids into intoxicating products that fell outside traditional marijuana regulations.
The result was a rapidly expanding marketplace for hemp-derived THC beverages, edibles, vapes and other products.
The federal restrictions were originally scheduled to take effect Nov. 12, 2026. However, Congress approved a four-week delay, moving the implementation date for the majority of the restrictions to Dec. 11. The initial phase took effect Nov. 12, targeting synthetic cannabinoids that cannot be naturally produced by the cannabis plant.
According to NPR’s reporting on the initial implementation, the delay means the broader restrictions on hemp-derived intoxicating products remain pending while lawmakers consider alternatives.
A Different Approach to Hemp Regulation
The Hemp Guardrails Act would seek to replace the impending restrictions with a federal regulatory structure administered by the Food and Drug Administration (FDA).
Under the proposal, consumers would need to be at least 21 to purchase or possess consumable hemp products. The FDA would establish requirements for child-resistant packaging, labeling, manufacturing and testing.
The legislation would also prohibit misleading packaging, imitation branding and advertising targeting children. It would authorize FDA inspections, product seizures and enforcement actions involving adulterated or misbranded products.
However, the proposal would not preserve every product currently available in the hemp-derived THC marketplace.
The bill would prohibit raw floral hemp material, smokable hemp flower and hemp pre-rolls intended for inhalation. It would also prohibit delta-8 THC, delta-10 THC and THC-O products, as well as synthetic cannabinoids.
Unlike smokable hemp products and certain intoxicating cannabinoids that would be prohibited, the Hemp Guardrails Act specifically identifies beverages as an eligible product category under its proposed federal framework. That means THC-infused seltzers, tonics and other ready-to-drink products would not automatically be eliminated from the marketplace. However, manufacturers would need to meet new federal requirements, including age restrictions, product testing, labeling, child-resistant packaging and manufacturing standards. Products containing delta-8 THC, delta-10 THC, THC-O or synthetic cannabinoids would be prohibited, potentially forcing brands using those ingredients to reformulate or discontinue certain offerings.
The distinction is particularly important for beverage manufacturers that rely on hemp-derived delta-9 THC, which could remain eligible under the proposed framework, provided their products meet the bill’s requirements. The legislation could therefore preserve a substantial portion of the emerging hemp beverage market while eliminating products and formulations lawmakers consider inappropriate for an unregulated retail environment.
Another significant provision would modify the federal definition of hemp, establishing a 1% total THC threshold on a dry-weight basis for hemp cultivation. The change would provide farmers with additional flexibility while establishing new restrictions on finished consumer products.
The legislation would also establish categories for hemp-derived cannabinoid products and dietary supplements under the Federal Food, Drug and Cosmetic Act. It would preserve access to qualifying hemp-derived CBD products and require hemp products to be cultivated, processed, finished and packaged in the United States.
States would retain the authority to implement stricter regulations.
The senators’ official legislative announcement outlines the proposed restrictions and consumer protections.
States Already Feeling the Impact
While federal lawmakers debate the future of the industry, some states have already moved ahead with restrictions of their own.
In a Nov. 12 report, NPR’s Frank Morris examined how several states were implementing their own hemp product prohibitions ahead of the federal deadline. Missouri was among the states where restrictions took effect that day, forcing some businesses to close.
Melissa Eigenmann, owner of Prohibition Cannabis in Kansas City, told NPR that the new restrictions would force her to lay off employees and shut down her business. She cited potential fines of $5,000 per transaction as making continued operations financially unviable.
The potential economic consequences extend beyond individual retailers. Economist Beau Whitney estimated that the federal ban could eliminate approximately 38,000 businesses and $28 billion in sales. Those figures illustrate the economic stakes for hemp farmers, manufacturers, retailers and other businesses operating throughout the supply chain.
Minnesota businesses are also preparing for the possibility that the federal restrictions will take effect. Although the state’s existing hemp regulations allow products with higher THC quantities per container than the proposed federal limit, uncertainty surrounding federal policy has already prompted some businesses to leave the market or adjust their purchasing strategies.
Bob Galligan, director of government and industry relations for the Minnesota Craft Brewers Guild, told MPR News that the proposed legislation could help preserve regulated businesses while establishing stronger consumer protections.
Galligan also cautioned that reversing the federal ban would not immediately restore the industry. Farmers make planting decisions months ahead of harvest and manufacturers need time to produce inventory. As a result, businesses that have already reduced operations could face continued supply chain challenges even if Congress ultimately intervenes.
Legislative Opposition Remains
Despite bipartisan support for the Hemp Guardrails Act, the proposal faces opposition from lawmakers who believe the federal restrictions should remain in place.
Sen. Ted Budd (R-N.C.) has criticized efforts to prevent the ban, arguing that a regulatory alternative would preserve access to products associated with addiction and public health concerns. His opposition could complicate efforts to include hemp provisions in broader government funding legislation.
The legislative timeline presents another challenge. Congress is entering its lame-duck session, leaving lawmakers with limited time to advance the proposal before the Dec. 11 deadline.
One possible route involves attaching hemp-related provisions to a continuing resolution, the temporary spending legislation Congress uses to maintain government funding.
Rep. James Comer (R-Ky.), who has also supported efforts to avert the federal prohibition, has identified a government funding package as a potential vehicle for delaying or rewriting the restrictions.
The Hemp Guardrails Act would therefore need to gain sufficient congressional support or find a path into a broader legislative package before the deadline.
For the hemp industry, the outcome could determine whether the federal government moves forward with a sweeping prohibition or establishes a regulatory system that allows a more limited category of hemp-derived cannabinoid products to remain commercially available.
For regulators, the debate raises broader questions about the appropriate distinction between hemp and marijuana, federal oversight of cannabinoid products and how states can maintain their own regulatory systems within a national framework.
Feature photo by Rick Proctor on Unsplash.

